Patient advocates were asked for their perspectives on the structural barriers to adherence to antiretroviral treatment among patients living with HIV. Poverty-related barriers were transport difficulties, food insecurity and patients’ receipt of a disability grant. Institutional barriers were long waiting times at clinics, negative experiences with clinic staff, low levels of health literacy and poor access to substance abuse treatment. Social and cultural barriers were the role of traditional healing practices, the influence of charismatic churches and perceived stigmatization. We offer a perspective on assisting patients living with HIV in addressing these key structural barriers to adherence.
Agar, M., & Hobbs, J.R. ( 1985). How to grow schemata out of interviews. In J. W. D. Dougherty (Ed.), Directions in cognitive anthropology (pp. 213-232). Urbana, IL: University of Illinois Press.
2.
Babalola, S., Fatusi, A., & Anyanti, J. ( 2009). Media saturation, communication exposure and HIV stigma in Nigeria. Social Science & Medicine, 68, 1513-1520.
3.
Bangsberg, D.R. ( 2006). Less than 95% adherence to Nonnucleoside Reverse-Transcriptase Inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43, 939-941.
4.
Bardeguez, A.D., Lindsey, J.C., Shannon, M., Tuomala, R.E., Cohn, S.E., Smith, E., ... Read, J.S. ( 2008). Adherence to antiretrovirals among US women during and after pregnancy. Journal of Acquired Immune Deficiency Syndromes , 48, 408-417.
5.
Bearman, K.J., & La Greca, A.M. (2002). Assessing friends’ support of adolescents’ diabetes care: The Diabetes Social Support Questionnaire-Friends version. Journal of Pediatric Psychology, 27, 417-428.
6.
BIG Fact Sheet #1. (2001). Overcoming dependency with a BIG. http://www.big.org.za/index.php?option=articles&task=viewarticle&artid=5 (accessed 11 November 2009).
7.
Breen, A., Swartz, L., Joska, J., Flisher, A.J., & Corrigall, J. ( 2007). Adherence to treatment in poorer countries: A new research direction. Psychiatric Services, 58, 567-568.
8.
Bronfenbrenner, U. ( 1972). Influences on human development. Fort Worth, TX: Dryden Press.
9.
Brown, L., Mcintyre, K., & Trujillo, L. ( 2003). Interventions to reduce HIV/AIDS stigma: What have we learned? AIDS Education & Prevention, 15, 49-69.
10.
Dorrington, R.E., Bradshaw, D., Johnson, L.F., & Budlender, D. (2004). The demographic impact of HIV/ AIDS in South Africa: National indicators for 2004. Joint publication by the Centre for Actuarial Research, the Burden of Disease Research Unit (Medical Research Council) and the Actuarial Society of South Africa .
11.
Fehringer, J., Bastos, F.I., Massard, E., Maia, L., Pilotto, J.H., & Kerrigan, D. ( 2006). Supporting adherence to highly active antiretroviral therapy and protected sex among people living with HIV/AIDS: The role of patient-provider communication in Rio De Janeiro, Brazil. AIDS Patient Care and STDs, 20, 637-648.
12.
Friedland, G., Harries, A., & Coetzee, D. ( 2007). Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. Journal of Infectious Diseases , 196, S114-S123.
13.
Grodensky, C.A., Golin, C.E., Bolan, M.S., Patel, S.N., Quinlivan, E.B., & Price, M. ( 2008). Translating concern into action: HIV care providers’ views on counselling patients about HIV prevention in the clinical setting . AIDS Behavior, 12, 404-411.
14.
Hardon, A.P., Akurut, D., Comoro, C., Ekezie, C., Irunde, H.F., Gerrits, T., ... Laing, R. ( 2007). Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care , 19, 658-665.
15.
Hawkins, C., & Murphy, R. ( 2007). Adherence to antiretroviral therapy in resource limited settings: Everything matters. AIDS, 21, 1041-1042.
16.
Holmes, W.C., Bilker, W.B., Wang, H., Chapman, J., & Gross, R. ( 2007). HIV/AIDS-specific Quality of Life and adherence to antiretroviral therapy over time. Journal of Acquired Immune Deficiency Syndrome , 46, 323-327.
17.
Hosseinipour, M.C., Kazemba, P.N., Sanne, I.M., & van der Hoorst, C.M. (2002). Challenges in delivering antiretroviral treatment in resource poor countries. AIDS , 16(suppl.4), 177-187.
18.
Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E., ... NIMH Healthy Living Project Team. (2003). Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Health Living Project. AIDS Patient Care, 17, 645-656.
19.
Kagee, A., Remien, R., Hoffman, S., Campos, L., & Swartz, L. ( 2010). Structural barriers to ART adherence in resource-constrained settings: Challenges and potential ways forward. Global Public Health: An International Journal for Research, Policy, and Practice, 1. First published on 26 May 2010.
20.
Kale, R. ( 1995). South Africa’s Health. Traditional healers in South Africa: A parallel health care system. British Medical Journal , 310, 1182-1185.
21.
Kilbourne, A.M., Reynolds, C.F., Good, C.B., & Sereika, S.M. ( 2005). How does depression influence diabetes medication adherence in older patients? American Journal of Geriatric Psychiatry , 13, 202-210.
22.
Levine, A.J., Hinkin, C.H., Castellon, S.A., Mason, K.I., Lam, M.N., Perkins, A., ... Hardy, D.J. ( 2005). Variations in patterns of Highly Active Antiretroviral Therapy (HAART) adherence. AIDS and Behaviour, 9, 355-362.
23.
MacQueen, K.M., McLellan, E., Kay, K., & Milstein, B. ( 1998). Codebook development for team-based qualitative research . Cultural Anthropology Methods Journal, 10(2), 31-36.
24.
Malta, M., Petersen, M.L., Claire, S., Freitas, F., & Bastos, F.I. ( 2005). Adherence to antiretroviral therapy: A qualitative study with physicians from Rio de Janeiro, Brazil. Cad Saude Publica , 21, 1424-1432.
25.
Mehta, S., Moore, R.D., & Graham, N.M.H. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
26.
Mills, E.J., Nachega, J.B., Bangsberg, D.R., Singh, S., Rachlis, B., Wu, P., ... Cooper, C. ( 2006). Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine, 3, 2039-2064.
27.
Nachega, J.B., Knowlton, A.R., Deluca, A., Schoeman, J.H., Watkinson, L.Efron, A., ... Maartens, G. ( 2006). Treatment support to improve adherence to Antiretroviral Therapy in HIV-infected South African adults: A qualitative study. Journal of Acquired Immune Deficiency Syndrome, 43(suppl. 1), 127-133.
28.
Nattrass, N. ( 2004). Trading off income and health: AIDS and the disability grant. Cape Town: Centre for Social Science Research, University of Cape Town. http://www.cssr.uct.ac.za/sites/cssr.uct.ac.za/files/pubs/wp82.pdf (accessed 6 September 2009).
29.
Orrell, C., Bangsberg, D.R., Badri, M., & Wood, R. ( 2003). Adherence is not a barrier to successful Antiretroviral Therapy in South Africa. AIDS, 17, 1369-1375.
30.
Schneider, J., Kaplan, S.H., Greenfield, S., Li, W., & Wilson, I.B. ( 2004). Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. Journal of General International Medicine, 19, 1096-1103.
31.
Shriver, M.D., Everett, C., & Morin, S.F. ( 2000). Structural interventions to encourage primary HIV prevention among people living with HIV. AIDS, 14(suppl.1), 57-62.
32.
Strauss, A.L., & Corbin, J.M. ( 1998). Basics of qualitative research: Techniques and procedures for developing grounded theory. London: SAGE.
33.
Sumartojo, E. ( 2000). Structural factors in HIV prevention: Concepts, examples, and implications for research. AIDS, 14(supp. 1), 4-10.
34.
Swartz, L. & Dick, J. ( 2002). Managing chronic disease in less developed countries . British Medical Journal, 325, 915-916.
35.
Trzynka, S.L., & Erlen, J.A. ( 2004). HIV disease susceptibility in women and the barriers to adherence. Medsurg Nursing, 13, 97-104.
36.
Tucker, J.S., Orlando, M., Burnam, A., Sherbourne, C.D., Kung, F.Y., & Gifford, A.L. ( 2004). Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23, 363-370.
37.
UNAIDS/WHO (2008). UNAIDS 2008 Report on the Global AIDS Epidemic: Status of the global HIV epidemic . http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/default.asp (accessed 6 September 2009).
38.
Walker, L., Reid, G., & Cornell, M. ( 2004). Waiting to happen. Cape Town: Double Storey Books.
39.
Wanyama, J., Castelnuovo, B., Wandera, B., Mwebaze, P., Kambugu, A., Bangsberg, D.R., & Kamya, M.R. ( 2007). Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS, 21, 1486-1487.
40.
Ware, N.C., Idoko, J., Kaaya, S., Biraro, I.A., Wyatt, M.A., Agbaji, O., ... Bangsberg, D. R. (2009). Explaining adherence success in Sub-Saharan Africa: An ethnographic study. Plos Medicine, 6, 0039-0047.
41.
Weidle, P.J., Wamai, N., Solberg, P., Liechty, C., Sendagala, S., Were, W., ... Bunnell, R. ( 2006). Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. The Lancet, 368, 1587-1594.
42.
Wong, I.Y., Lawrence, N.V., Struthers, H., McIntyre, J., & Friedland, G.H. (2006). Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. Journal of Acquired Immune Deficiency Syndrome, 43(suppl.1), 142-148.
43.
World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. http://www.who.int/chp/knowledge/publications/adherence_report/en/ (accessed 16 March 2010).
